Please see below all current gynaecological cancer clinical trials of the Central Coast Cancer Centre.
Name: ICON 9
An international phase III randomised study to evaluate the efficacy of maintenance therapy with olaparib and cediranib or olapartib alone in patients with relapsed platinum sensitive-ovarian cancer following a response to platinum-based chemotherapy.
Principal Investigator: Dr Craig Kukard
Study Coordinator: Michelle Dixon
Condition: Ovarian Cancer
For more information about medical oncology clinical trials please contact the Nurse Unit Manager on 02 4320 9890 or see: